FDA/CDC

FDA authorizes booster shot for immunocompromised Americans


 

The FDA has authorized a third dose of either the Pfizer or Moderna COVID-19 vaccines for people with compromised immune systems.

FDA icon

The decision, which came late on Aug. 12, was not unexpected and a Centers for Disease Control and Prevention (CDC) panel meeting Aug. 13 is expected to approve directions to doctors and health care providers on who should receive the booster shot.

“The country has entered yet another wave of the COVID-19 pandemic, and the FDA is especially cognizant that immunocompromised people are particularly at risk for severe disease. After a thorough review of the available data, the FDA determined that this small, vulnerable group may benefit from a third dose of the Pfizer-BioNTech or Moderna Vaccines,” acting FDA Commissioner Janet Woodcock, MD, said in a statement.

Those eligible for a third dose include solid organ transplant recipients, those undergoing cancer treatments, and people with autoimmune diseases that suppress their immune systems.

Meanwhile, White House officials said Aug. 12 they “have supply and are prepared” to give all U.S. residents COVID-19 boosters -- which, as of now, are likely to be authorized first only for immunocompromised people.

“We believe sooner or later you will need a booster,” Anthony Fauci, MD, said at a news briefing Aug. 12. “Right now, we are evaluating this on a day-by-day, week-by-week, month-by-month basis.”

He added: “Right at this moment, apart from the immunocompromised -- elderly or not elderly -- people do not need a booster.” But, he said, “We’re preparing for the eventuality of doing that.”

White House COVID-19 Response Coordinator Jeff Zients said officials “have supply and are prepared” to at some point provide widespread access to boosters.

The immunocompromised population is very small -- less than 3% of adults, said CDC Director Rochelle Walensky, MD.

Meanwhile, COVID-19 rates continue to rise. Dr. Walensky reported that the 7-day average of daily cases is 132,384 -- an increase of 24% from the previous week. Average daily hospitalizations are up 31%, at 9,700, and deaths are up to 452 -- an increase of 22%.

In the past week, Florida has had more COVID-19 cases than the 30 states with the lowest case rates combined, Mr. Zients said. Florida and Texas alone have accounted for nearly 40% of new hospitalizations across the country.

A version of this article first appeared on WebMD.com.

Recommended Reading

Delta variant could drive herd immunity threshold over 80%
MDedge Hematology and Oncology
Analysis: Don’t want a vaccine? Be prepared to pay more for insurance
MDedge Hematology and Oncology
Will the Delta variant peak and then burn out?
MDedge Hematology and Oncology
WHO calls for pause on booster doses
MDedge Hematology and Oncology
Despite retraction, study using fraudulent Surgisphere data still cited
MDedge Hematology and Oncology
Moderna says boosters may be needed after 6 months
MDedge Hematology and Oncology
CDC: Vaccination may cut risk of COVID reinfection in half
MDedge Hematology and Oncology
FDA may okay COVID booster for vulnerable adults before weekend: Media
MDedge Hematology and Oncology
Hospitals struggle to find nurses, beds, even oxygen as Delta surges
MDedge Hematology and Oncology
German nurse suspected of giving saline instead of COVID-19 vaccine
MDedge Hematology and Oncology